Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
| Image |  |
|---|---|
| Description | scientific article published on 15 August 2023 |
| Author/s |
author: Elsa Kalbacher Ignacio Romero Mansoor Raza Mirza Esther Drill Peter Vuylsteke Felix Hilpert Anneke Westermann Josep M. del Campo David M. O'Malley Cristina Churruca Nicoletta Colombo Martin K Oehler John Farley David Cibula Sandro Pignata Ignace Vergote Jalid Sehouli Robert L Coleman Regina Berger Carol Aghajanian Gopa Iyer Susana Banerjee Andrew R Clamp Kathleen N. Moore Rachel N. Grisham Christian Marth Bradley J. Monk Amit M. Oza Gunnar B. Kristensen Isabelle Ray-Coquard |
| Publication date | August 15, 2023 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |